Genital graft-versus-host-disease can be a lifelong risk for female stem cell or bone marrow transplant recipients. The presentation reviews the symptoms of vaginal and vulvar GVHD and discusses treatments that can restore women to full sexual health and functioning. Many thanks to Kadmon, a Sanofi company, and Syndax Pharmaceuticals, whose support, in part, made this webinar possible.

Graft-versus-host disease (GVHD) often affects the genitals in patients who undergo a stem cell transplant using cells from a donor (allogeneic transplant). Genital GVHD can cause pain and can interfere with sexual intimacy. Learn how to detect and treat genital GVHD in both men and women.

Ovarian failure, estrogen deficiency, decreased sex drive, infertility and vaginal graft-versus-host disease are a concern for many women after a stem cell transplant. This presentation discusses what causes these problems and treatment options, particularly for women with vaginal graft-versus-host disease (GVHD).